IntegraGen is a company specializing in the decryption of the human genome providing interpretable genomic analyses and bioinformatic tools for researchers and clinicians.
Genomic Services
Bioinformatics & Bioanalysis
Investors
Latest news // Archive
-
News
Potential implication of urinary tract infections (UTIs) in bladder cancer development
-
News
New discoveries in DMD development open new perspectives for the disease diagnosis and therapeutics
-
Press releases
IntegraGen reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31, 2020